AstraZeneca India’s Q1 net profit declines 45 per cent
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period a year ago
AstraZeneca Pharma India yesterday reported a 45.03 per cent decline in its net profit to Rs 10.24 crores for the June-ended quarter. The company had posted a net profit of Rs 18.63 crores for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period a year ago, it added.
The company’s board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.
- Advertisement -